methyl 2-(aminomethyl)-5-furanoate | 73751-06-1

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: methyl 2-(aminomethyl)-5-furanoate
• 英文别名: Methyl 5-(aminomethyl)furan-2-carboxylate
• CAS: 73751-06-1
• 化学式: C₇H₉NO₃
• mdl: MFCD06803201
• 分子量: 155.153
• InChiKey: HXZRHZUUJMJRJT-UHFFFAOYSA-N

物化性质

• 沸点：
  264.2±30.0 °C(Predicted)
• 密度：
  1.192±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.1
• 重原子数：
  11
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.285
• 拓扑面积：
  65.5
• 氢给体数：
  1
• 氢受体数：
  4

安全信息

• 海关编码：
  2932190090

反应信息

• 作为反应物：
  描述：

  methyl 2-(aminomethyl)-5-furanoate 在 lithium hydroxide 、 三氟乙酸 作用下， 以 四氢呋喃 、 甲醇 、 二氯甲烷 、 水 为溶剂， 反应 2.67h， 生成 5-(Aminomethyl)furan-2-carboxylic acid;2,2,2-trifluoroacetic acid
  参考文献：
  名称：

  Cyclic trimer of 5-(aminomethyl)-2-furancarboxylic acid as a novel synthetic receptor for carboxylate recognition

  摘要：

  A novel 18-membered cyclic oligopeptide 1 based on 5-(aminomethyl)-2-furancarboxylic acid (2), is developed as an excellent receptor for carboxylate binding having an association constant of 8.64x10(3) M-1 for tetrabutylammonium acetate in CD3CN. The synthesis of 1 was achieved by a high-yielding cyclotrimerization reaction of the unfunctionalized furan amino acid 2. (C) 2002 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0040-4039(01)02367-x
• 作为产物：
  描述：

  果糖 在 盐酸 、 sodium azide 、 三苯基膦 、 magnesium chloride 作用下， 以 甲醇 、 N,N-二甲基甲酰胺 、 甲苯 为溶剂， 反应 10.5h， 生成 methyl 2-(aminomethyl)-5-furanoate
  参考文献：
  名称：

  Cyclic trimer of 5-(aminomethyl)-2-furancarboxylic acid as a novel synthetic receptor for carboxylate recognition

  摘要：

  A novel 18-membered cyclic oligopeptide 1 based on 5-(aminomethyl)-2-furancarboxylic acid (2), is developed as an excellent receptor for carboxylate binding having an association constant of 8.64x10(3) M-1 for tetrabutylammonium acetate in CD3CN. The synthesis of 1 was achieved by a high-yielding cyclotrimerization reaction of the unfunctionalized furan amino acid 2. (C) 2002 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0040-4039(01)02367-x

文献信息

• Aldimines of Cardenolides and Cardenolide-Glycosides
  作者：I. F. Makarevich、Yu. I. Gubin、R. Megges

  DOI：10.1007/s10600-005-0142-7

  日期：2005.5

  New aldimines were synthesized from the cardenolide strophantidin and cardenolide-glycosides erysimin and cymarin and included morpholine, nitrile, pyridine, furan, hydroxy- and methoxyphenyl, piperidine, and other derivatives. An effective modified method for synthesizing aldimines was proposed. 52 new compounds were synthesized. Their structures were confirmed by IR and PMR spectra and elemental analysis.

  新的烯胺由毛地黄毒苷和毛地黄毒糖苷、毛地黄苷以及诸如吗啉、腈、吡啶、呋喃、羟基和甲氧基苯基、哌啶以及其他衍生物合成。提出了一种有效的合成烯胺改性方法。合成了52种新化合物。它们结构由红外和质子磁共振谱和元素分析确证。
• ANTIVIRAL COMPOUNDS AND USE THEREOF
  申请人：Yager Kraig

  公开号：US20090275583A1

  公开（公告）日：2009-11-05

  The invention relates to compounds, pharmaceutical compositions and methods useful for treating viral infection.

  这项发明涉及化合物、药物组合物和用于治疗病毒感染的方法。
• Exploring the scope of DBU-promoted amidations of 7-methoxycarbonylpterin
  作者：Anna R Bockman、Jeffrey M Pruet

  DOI：10.3762/bjoc.16.46

  日期：——

  medicinally relevant pteridine derivatives. Reactions which expedite the development of new pterins are thus of great importance. Through a dual role of diazabicycloundecene (DBU), 7-carboxymethylpterin is converted to the soluble DBU salt, with additional DBU promoting an ester-to-amide transformation. We have explored this reaction to assess its scope and identify structural features in the amines

  蝶呤的合成效用常常受到该杂环臭名昭著的不溶性的阻碍，从而减缓了与医学相关的蝶啶衍生物的开发。因此，加速新蝶呤开发的反应非常重要。通过二氮杂双环十一碳烯（DBU）的双重作用，将7-羧甲基蝶呤转化为可溶性DBU盐，另外的DBU促进了酯到酰胺的转化。我们已经研究了该反应以评估其范围并确定对胺有重大影响的结构特征，使用拟一级动力学模型监控了反应动力学，并进一步调整了反应条件以使产物形成少至5分钟，收率通常> 80％。
• HETEROCYCLIC COMPOUND AND USE OF THE SAME
  申请人：Nishio Tetsuya

  公开号：US20110319618A1

  公开（公告）日：2011-12-29

  Provided is a compound represented by general formula (6) and pharmaceutically acceptable salts thereof. (In the formula, R 1 is a hydrogen atom or a C 1-6 alkyl group; R 2 is a hydrogen atom or a C 1-6 alkyl group; R 3 is a hydrogen atom, a halogen atom, a C 1-6 alkyl group, or a C 1-6 haloalkyl group.)

  提供的是以一般式（6）表示的化合物及其药用可接受的盐。（在该式中，R1是氢原子或C1-6烷基；R2是氢原子或C1-6烷基；R3是氢原子、卤素原子、C1-6烷基或C1-6卤代烷基。）
• Heterocyclic compound and use of the same
  申请人：Nishio Tetsuya

  公开号：US08895565B2

  公开（公告）日：2014-11-25

  Provided is a compound represented by general formula (6) and pharmaceutically acceptable salts thereof. (In the formula, R1 is a hydrogen atom or a C1-6 alkyl group; R2 is a hydrogen atom or a C1-6 alkyl group; R3 is a hydrogen atom, a halogen atom, a C1-6 alkyl group, or a C1-6 haloalkyl group.)

  提供的是由一般式（6）表示的化合物及其药用可接受盐。（在公式中，R1是氢原子或C1-6烷基；R2是氢原子或C1-6烷基；R3是氢原子、卤素原子、C1-6烷基或C1-6卤代烷基。）